Le Lézard
Classified in: Health
Subject: PDT

Infuse Your Life Health Products, Inc. is coming to Amazon with its cardiovascular supplements


BOCA RATON, Fla., Nov. 16, 2018 /PRNewswire/ -- Infuse Your Life Health Products, Inc. will bring its two unique cardiovascular products to Amazon soon.

Soul: Cardiovascular Sparkling Water boosts cardiovascular and cell health performance, fights diabetes by reinforcing healthy glucose levels and promotes healthy cholesterol and blood pressure levels.

The Canadian health company, which recently announced it was breaking into the American health supplement industry, has created two liquid-based products to promote cardiovascular health. G-Cubed: Plant-Based Support and Soul: Cardiovascular Sparkling Water.

Cardiovascular disease and diabetes have a harmful symbiotic relationship. Heart disease is the leading cause of death for both women and men in the United States where as the American Diabetes Association said more than 30 million Americans had diabetes in 2015. Heart disease and strokes are the most common causes of death for diabetic adults. This is why both Infuse Your Life Health Products target the heart and healthy blood sugar levels.

G-Cubed: Plant-Based Support, which contains no preservatives or artificial sweeteners, helps boost cardiovascular and cell health performance, maintain healthy glucose levels and promote healthy cholesterol and blood pressure levels.

Soul: Cardiovascular Sparkling Water boosts cardiovascular and cell health performance, fights diabetes by reinforcing healthy glucose levels and promotes healthy cholesterol and blood pressure levels.

"G-Cubed and Soul are very popular heart healthy products in Canada," said Thomas Lasic, founder and president of Infuse Your Life Health Products, Inc. "As a company, we really want to focus on heart healthy products and these two products do just that."

A grassroots company from British Columbia, Canada, Infuse Your Life Health Products Inc. saw a market flooded with products with misleading labels and decided to focus on minimizing the number of ingredients in its formulas to really focus on purity, quality and transparency for the good of the consumer.

"There is no more important human organ than the heart," Lasic said. "With G-Cubed and Soul, our consumers can enjoy the benefits of a healthy heart."

For more information on G-Cubed: Plant-based Cardiovascular Support and Soul: Cardiovascular Sparkling Water, visit www.drinkgcubed.com and follow on Facebook, Instagram and YouTube.

Please direct inquiries to:
Michelle Bizet, 561-544-0719
[email protected]

SOURCE Infuse Your Life Health Products Inc.


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: